Time New York: Wed 28 Sep 13:09 pm  |  Save 15% on H&R Block Online

  

FDA approval stocks, news and press releases including pending drugs or clinical trials.

caticonslite_bm_alt

Upsher-Smith Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations

caticonslite_bm_alt

U.S. FDA Accepts NDA Filing for Boehringer Ingelheim’s Investigational Nintedanib and Grants Priority Review Designation for the Treatment of Idiopathic Pulmonary Fibrosis

caticonslite_bm_alt

BioLight Announces Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform

caticonslite_bm_alt

Pharma Two B Expands List of Clinical Sites Enrolling for Phase IIb Study of P2B001 for PD to 25

caticonslite_bm_alt

Inova Labs Receives FDA Clearance for Activox DUO2™ – The First Integrated Stationary and Portable Oxygen Concentrator System

caticonslite_bm_alt

ReShape Medical Submits PMA Application to FDA for Non-Surgical Weight Loss Device

caticonslite_bm_alt

Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE Antibody Blinatumomab In Acute Lymphoblastic Leukemia

caticonslite_bm_alt

Expanding Orthopedics Inc. has Obtained CE Mark for its Unique FLXfit™, 3D Expandable Interbody Cage

caticonslite_bm_alt

Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens

caticonslite_bm_alt

Surgical Theater’s Surgical Navigation Advanced Platform Receives FDA Clearance